Cyclophosphamide Attenuates Fibrosis in Lupus Nephritis by Regulating Mesangial Cell Cycle Progression - Ma, Yuehong; Fang, Ling; Zhang, Rui; Zhao, Peng; Li, Yafeng; Li, Rongshan (Disease markers, 2021)
Keywords: Actin; Animal tissues; Animals; Apoptosis; Biotechnology; Cell cycle; Cell Cycle Checkpoints; Cell growth; Cell Proliferation; Cells, Cultured; Chronic conditions; Cyclin-dependent kinase; Cyclin-dependent kinase inhibitors; Cyclins; Cyclophosphamide; Cyclophosphamide - pharmacology; Disease; Female; Fibrosis; Fibrosis - drug therapy; Fibrosis - etiology; Fibrosis - pathology; Flow cytometry; G1 phase; Gene expression; Growth factors; Histopathology; IL-1β; Immunosuppressive Agents - pharmacology; Inflammation; Interleukins; Kidneys; Kinases; Laboratory animals; Lupus; Lupus nephritis; Lupus Nephritis - complications; Mesangial cells; Mesangial Cells - drug effects; Mesangial Cells - metabolism; Mesangial Cells - pathology; Mice; Mice, Inbred C57BL; mRNA; Muscles; Nephritis; Platelet-derived growth factor; Smooth muscle; Systemic lupus erythematosus; United States--US; China